Jabil Acquires Pharmaceutics International (Pii)

AIS Healthcare Acquires Hunt Valley PharmaLAB

February 25, 2020

Healthcare Services

AIS Healthcare, a Dallas-based provider of targeted drug delivery and infusion care, has acquired Hunt Valley PharmaLAB, a 503A compounding pharmacy focused on ophthalmology medications based in Hunt Valley, Maryland. The acquisition expands AIS Healthcare's capabilities into ophthalmology and will allow the combined organization to produce custom ophthalmic medications for a larger patient base across the U.S.

PCI Pharma Services Acquires Ajinomoto Althea

May 1, 2025

Healthcare Services

PCI Pharma Services has completed the acquisition of Ajinomoto Althea, Inc., a US-based sterile fill-finish CDMO previously owned by Ajinomoto Co., Inc. The deal expands PCI’s US sterile manufacturing footprint in San Diego—adding prefilled syringe and cartridge aseptic capabilities, lyophilization and high-potent vial filling (including ADC support)—and is part of a multi-year, roughly $1 billion investment strategy to broaden advanced drug delivery and fill‑finish capacity.

Olympus Partners Acquires PAI Pharma

February 24, 2025

Pharmaceuticals

Olympus Partners has acquired PAI Pharma, a leading U.S. developer, manufacturer and distributor of generic oral liquid medicines. The platform was previously owned by Enhanced Healthcare Partners and Bourne Partners Strategic Capital; terms were not disclosed and Monroe Capital provided senior financing for the deal.

PAI Partners to Acquire SGD Pharma from China Jianyin Investment (JIC)

June 16, 2021

Packaging

PAI Partners has made a binding offer to acquire SGD Pharma, a global manufacturer of primary glass packaging for the pharmaceutical industry, from China Jianyin Investment Ltd. (JIC). The contemplated buyout, subject to employee consultations, Ministry of Finance of China approvals and antitrust clearance, aims to accelerate SGD Pharma’s growth through organic investment and external initiatives.

Bain Capital and Kohlberg Lead Strategic Investment in PCI Pharma Services

July 14, 2025

Healthcare Services

PCI Pharma Services, a Philadelphia-based contract development and manufacturing organization (CDMO), received a strategic growth investment co-led by Bain Capital and existing lead investor Kohlberg, with significant reinvestment from Mubadala and a continuing minority stake from Partners Group. The capital will be used to accelerate PCI's organic and inorganic growth, expand sterile fill-finish and specialized manufacturing capacity, and broaden its geographic footprint to support biopharma customers and U.S. pharmaceutical supply-chain resilience.

Aterian Investment Partners Acquires Contract Pharmaceuticals Limited

June 6, 2024

Pharmaceuticals

Aterian Investment Partners, through an affiliate, has acquired Contract Pharmaceuticals Limited (CPL), a Mississauga-based CDMO specializing in non-sterile liquid and semi-solid pharmaceutical and OTC products. Aterian said it will invest in people, technology and processes to support CPL's next phase of growth and further strengthen its position serving global pharmaceutical customers.